- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Durect Corp+ Add to Watchlist
DRRX:US2.7900 USD 0.1900 7.31%
As of 16:30:00 ET on 06/02/2015.
Company Profile for Durect Corp (DRRX)
Durect Corporation develops and commercializes pharmaceutical systems for the treatment of chronic diseases. The pharmaceutical systems provide therapy for chronic diseases or conditions by replacing multiple injection therapy or oral dosing, improving drug efficacy, reducing side effects, and ensuring dosing compliance.
Key Executives for Durect Corp (DRRX)
|Felix TheeuwesChairman/Chief Scientific Ofcr||James E BrownPresident/CEO/Co-Founder|
|Matthew J HoganCFO/Secretary||Judy R JoiceSenior VP:Operations|